首页> 外文期刊>CNS neuroscience & therapeutics. >The Pro‐inflammatory Cytokine Interleukin‐1β is a Key Regulatory Factor for the Postictal Suppression in Mice
【24h】

The Pro‐inflammatory Cytokine Interleukin‐1β is a Key Regulatory Factor for the Postictal Suppression in Mice

机译:促炎性细胞因子白介素-1β是小鼠抑制Post的关键调节因子。

获取原文
           

摘要

Summary Aims The postictal suppression ( PS ) is a common and important period following an epileptic seizure but has not been well studied. This study was designed to determine whether interleukin‐1β ( IL ‐1β) is involved in the PS . Methods The effects of IL ‐1β on the PS were tested in three independent seizure models induced by hippocampal kindling, maximal electroshock seizure ( MES ), and 4‐aminopyridine, respectively. Results IL ‐1R1 knockout or IL ‐1 RA enhanced the seizure refractory phenomenon without influencing the baseline seizure threshold in intermittent MES model. IL ‐1β attenuated the seizure refractory phenomenon without affecting the severity of the preceding seizures in hippocampal kindling model, while IL ‐1 RA enhanced it. Besides, IL ‐1β reduced the postictal EEG suppression period, while IL ‐1 RA prolonged it. And IL ‐1β showed no further effect on the postictal EEG suppression and seizure refractory phenomenon in IL ‐1R1 knockout mice. In addition, 30 min after intrahippocampal injection of 4‐aminopyridine, IL ‐1β increased the incidence of SE , while IL ‐1 RA prolonged the intervals between recurrent seizures. Conclusions This study provides the first direct evidence that IL ‐1β is key regulatory factor for the PS , and its receptor IL ‐1R1 may be a potential target for adjuvant treatment of postictal problems.
机译:摘要目的癫痫发作后的抑制是一个普遍而重要的时期,但尚未得到很好的研究。这项研究旨在确定白介素-1β(IL-1β)是否参与PS。方法在海马点燃,最大电休克发作(MES)和4-氨基吡啶诱发的三个独立的癫痫发作模型中分别测试了IL-1β对PS的影响。结果IL -1R1敲除或IL -1 RA增强了发作性难治性现象,而不会影响间歇性MES模型的基线发作阈值。 IL-1β减弱了癫痫发作的难治性现象,而不会影响海马点燃模型中先前发作的严重性,而IL-1RA则增强了这种现象。此外,IL-1β减少了后脑电图抑制期,而IL-1RA则延长了该期。 IL-1β对IL -1R1基因敲除小鼠的脑电图抑制和癫痫发作难治现象没有进一步影响。此外,海马内注射4-氨基吡啶后30分钟,IL-1β增加了SE的发生率,而IL -1 RA延长了发作间隔。结论这项研究提供了第一个直接证据,证明IL-1β是PS的关键调节因子,其受体IL -1R1可能是辅助治疗后遗症的潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号